Interestingly, treatment of MetS rats with candesartan promoted a significant decrease in the mRNA cargo of these pro-inflammatory components (AT1 and PRR mRNA expression) in EVs from MetS animals treated with candesartan (EVMetS+CAND) relative to EVMetS and even to EVControl (Figure 2A–C). This evidence concerns the gene AGTR1 and metabolic syndrome.